Vaccines

Vaccines

Impaired Humoral Responses to COVID-19 Vaccination in Patients with Waldenstrom Macroglobulinemia and Multiple Myeloma

Researchers at the National Cancer Institute Frederick have found that patients with symptomatic monoclonal gammopathies, including Waldenstrom macroglobulinemia and multiple myeloma, have impaired humoral responses to COVID-19 vaccination. The study compared the response to BNT162b2 mRNA vaccinations of patients with these conditions with healthy vaccine recipients and found that patients

Vaccines

Bharat Biotech's iNCOVACC Covid Vaccine Approved for Public Use, Priced at Rs 800 for Private Markets

Bharat Biotech International Limited has announced the approval and pricing of its COVID-19 intranasal vaccine, iNCOVACC, marking a significant milestone in the global fight against the pandemic. The vaccine, priced at Rs 800 (excluding GST) for private markets and Rs 325 (excluding GST) for government supplies, will be rolled out

Vaccines

Psychological Factors and Vaccine Conspiracy Beliefs Influence Influenza Vaccine Acceptance among Jordanian Healthcare Workers

Jordanian healthcare workers' attitudes towards influenza vaccination were evaluated in a recent study, which found that psychological determinants such as confidence, complacency, and collective responsibility play a significant role in vaccine acceptance. The study, conducted among 1218 healthcare workers, including nurses, physicians, and pharmacists, revealed that willingness to receive

Vaccines

mRNA-Loaded Lipid Nanoparticles Target Dendritic Cells for Cancer Immunotherapy

Research conducted by scientists at Hokkaido University has made significant strides in targeting dendritic cells for cancer immunotherapy using mRNA-loaded lipid nanoparticles. The study, published in the journal Pharmaceutics, aimed to optimize the size of the nanoparticles to enhance their delivery and effectiveness. The researchers found that a size range

Vaccines

Initial Safety Findings of COVID-19 Vaccination in Children Aged 6 Months to 5 Years

Recent data from the Centers for Disease Control and Prevention (CDC) indicates that COVID-19 vaccines have been widely administered to children aged 6 months to 5 years since June 2022, with approximately one million doses administered during June to August 2022. The CDC has reviewed adverse events and health impacts

Vaccines

FDA Approves Pfizer-BioNTech COVID-19 Bivalent Vaccine Booster Dose

Pfizer Inc. and BioNTech SE announced on Wednesday that the US Food and Drug Administration (FDA) has approved a 30-microgram booster dose of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, which targets both the original and Omicron BA.4/BA.5 strains. The companies emphasized that they will continue to provide both

Vaccines

Novavax Nuvaxovid™ COVID-19 Vaccine Receives Expanded Provisional Approval in New Zealand

Novavax's Nuvaxovid™ COVID-19 vaccine has been granted expanded provisional approval by New Zealand's Medsafe for use as a first or second booster dose in adults aged 18 and older. This approval makes Nuvaxovid the first and only protein-based COVID-19 vaccine available in New Zealand. The decision

Vaccines

COVID-19 Vaccination Clinic Opens at Great New York State Fair

The New York State Department of Health has opened a COVID-19 vaccination clinic on the grounds of the Great New York State Fair in Syracuse, offering Pfizer and Johnson and Johnson vaccines to fairgoers aged 5 and over. The clinic will be open for the entire 13-day run of the

Vaccines

Adjuvants Enhance Vaccine Responses in Neonates: Study

Researchers at the National University Hospital of Iceland have conducted a study to understand the effects of adjuvants on vaccine responses in neonates. The findings, published in Frontiers in Immunology, reveal that adjuvants can enhance the immune system's response to vaccines in newborns. This is crucial because neonates

Vaccines

Theory-Based, User-Centered Applications Boost Human Papillomavirus Vaccination Rates

Researchers have found that theory-based, user-centered applications can address the suboptimal coverage of human papillomavirus (HPV) vaccination among adolescents. According to a new report published in CIN Computers Informatics Nursing, the application should provide directions to appropriate clinics and HPV vaccine recommendations offered by nurses to mitigate hesitancy. The study

Vaccines

Polio Re-Emerges in Western Nations: Experts Warn of Potential Outbreaks

A highly infectious and once-eradicated disease is making a comeback in parts of the world, despite widely available and effective vaccines. Polio, a serious illness that can cause paralysis or death, has re-emerged in Western nations, including the UK and the US, sparking concerns of potential outbreaks in Canada. The

Vaccines

Novavax Initiates Phase 2b/3 Clinical Trial for COVID-19 Vaccine in Children

Novavax has initiated its Phase 2b/3 Hummingbird trial to evaluate the safety, effectiveness, and efficacy of its COVID-19 vaccine (NVX-CoV2373) in children aged six months through 11 years. The trial will assess the vaccine in infants, toddlers, and children, with participants having begun dosing in the six to 11-year-old